Startups
XYLO is pioneering neuroplastogens – next-generation therapeutics designed to rewire neural circuits and restore brain function. Combining advanced neuroscience with computational drug discovery, we are developing optimized treatments to revolutionize care for neurological and psychiatric conditions. Our mission is to deliver breakthrough therapies that address critical unmet needs and improve the lives of patients worldwide.
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2026 | Endless Frontier Labs | endlessfrontierlabs.com |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 10, 2025 | Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress | Announces Major Milestones at the JPM Healthcare Conference SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the ... |
Reviews 0
FAQ about Xylo Bio
Who has invested in Xylo Bio?
Parsers VC lists 2 investors of Xylo Bio, among them Endless Frontier Labs.
What has the press written about Xylo Bio?
Parsers VC has collected 2 articles mentioning Xylo Bio, among them “Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress” (Jan 10, 2025).
Is Xylo Bio still active?
Yes, Xylo Bio is active; its latest activity on Parsers VC dates from Sep 15, 2026.